Evotec SE (NASDAQ:EVO) ADRs surged 20% in premarket trading after a report that Triton Partners is considering a takeover offer for the German drug developer. The investment firm has been trying to ...
(Reuters) -Shares in Evotec soared 22% on Monday after private equity firm Triton confirmed a close to 10% stake in the German drug development company, and a media report said it was weighing a ...